Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Miller ML, Moreno AY, Aarde SM, Creehan KM, Vandewater SA, Vaillancourt BD, Wright MJ Jr, Janda KD, Taffe MA.

Biol Psychiatry. 2013 Apr 15;73(8):721-8. doi: 10.1016/j.biopsych.2012.09.010.

2.

Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

Miller ML, Aarde SM, Moreno AY, Creehan KM, Janda KD, Taffe MA.

Drug Alcohol Depend. 2015 Aug 1;153:29-36. doi: 10.1016/j.drugalcdep.2015.06.014.

3.

Impact of distinct chemical structures for the development of a methamphetamine vaccine.

Moreno AY, Mayorov AV, Janda KD.

J Am Chem Soc. 2011 May 4;133(17):6587-95. doi: 10.1021/ja108807j.

4.

Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.

Rüedi-Bettschen D, Wood SL, Gunnell MG, West CM, Pidaparthi RR, Carroll FI, Blough BE, Owens SM.

Vaccine. 2013 Sep 23;31(41):4596-602. doi: 10.1016/j.vaccine.2013.07.038.

5.

A vaccine against methamphetamine attenuates its behavioral effects in mice.

Shen XY, Kosten TA, Lopez AY, Kinsey BM, Kosten TR, Orson FM.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):41-8. doi: 10.1016/j.drugalcdep.2012.09.007.

6.

Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.

Gentry WB, Laurenzana EM, Williams DK, West JR, Berg RJ, Terlea T, Owens SM.

Int Immunopharmacol. 2006 Jun;6(6):968-77.

PMID:
16644483
7.

Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats.

Byrnes-Blake KA, Carroll FI, Abraham P, Owens SM.

Int Immunopharmacol. 2001 Feb;1(2):329-38.

PMID:
11360933
8.

Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.

McFadden LM, Hoonakker AJ, Vieira-Brock PL, Stout KA, Sawada NM, Ellis JD, Allen SC, Walters ET, Nielsen SM, Gibb JW, Alburges ME, Wilkins DG, Hanson GR, Fleckenstein AE.

Synapse. 2011 Aug;65(8):771-7. doi: 10.1002/syn.20902.

9.

Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period.

Hambuchen MD, Rüedi-Bettschen D, Williams DK, Hendrickson H, Owens SM.

Vaccine. 2014 Oct 29;32(47):6213-9. doi: 10.1016/j.vaccine.2014.09.025.

10.

Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response.

Hambuchen MD, Carroll FI, Rüedi-Bettschen D, Hendrickson HP, Hennings LJ, Blough BE, Brieaddy LE, Pidaparthi RR, Owens SM.

J Med Chem. 2015 Jun 11;58(11):4665-77. doi: 10.1021/acs.jmedchem.5b00220.

11.

Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats.

Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Vandewater SA, Parsons LH, Houseknecht KL, Dickerson TJ, Taffe MA.

PLoS One. 2012;7(8):e44652. doi: 10.1371/journal.pone.0044652.

12.
13.

Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats.

Byrnes-Blake KA, Laurenzana EM, Carroll FI, Abraham P, Gentry WB, Landes RD, Owens SM.

Eur J Pharmacol. 2003 Feb 14;461(2-3):119-28.

PMID:
12586207
14.

Pharmacokinetic antagonism of (+)-methamphetamine discrimination by a low-affinity monoclonal anti-methamphetamine antibody.

McMillan DE, Hardwick WC, Li M, Owens SM.

Behav Pharmacol. 2002 Sep;13(5-6):465-73.

PMID:
12394422
15.

Development of active and passive human vaccines to treat methamphetamine addiction.

Gentry WB, Rüedi-Bettschen D, Owens SM.

Hum Vaccin. 2009 Apr;5(4):206-13. Review.

16.

Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats.

Nakato Y, Abekawa T, Inoue T, Ito K, Koyama T.

Neurosci Lett. 2011 Oct 24;504(2):131-4. doi: 10.1016/j.neulet.2011.09.017.

PMID:
21945544
17.

Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.

White SJ, Laurenzana EM, Gentry WB, Hendrickson HP, Williams DK, Ward KW, Owens SM.

Toxicol Sci. 2009 Sep;111(1):27-36. doi: 10.1093/toxsci/kfp127.

18.

Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats.

Tien LT, Cai Z, Rhodes PG, Fan LW.

Behav Brain Res. 2011 Oct 10;224(1):166-73. doi: 10.1016/j.bbr.2011.05.038.

19.

Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice.

Itzhak Y, Martin JL.

Psychopharmacology (Berl). 2000 Aug;151(2-3):226-33.

PMID:
10972469
20.

A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats.

Li QQ, Luo YX, Sun CY, Xue YX, Zhu WL, Shi HS, Zhai HF, Shi J, Lu L.

J Neurochem. 2011 Dec;119(6):1271-81. doi: 10.1111/j.1471-4159.2011.07502.x.

Supplemental Content

Support Center